Workshop Day
Monday 29th January, 2024
9:00 am Registration & Morning Coffee
9:30 am Workshop A – Regulatory Workshop
Unravelling the Regulatory Roadmap for Allogeneic Products to Pave the Route to Commercial Success
Synopsis
Having a clear understanding of current regulations for preclinical, clinical and CMC
is essential in the progression of your allogeneic products and therapies. In this
regulatory workshop hear about new regulations and changes from experts from
regulatory bodies across Europe and have your burning questions answered by these
key players.
This workshop will cover:
• Recent guideline changes in Europe to inform on clinical trial design and data
requirements
• How new cell and gene therapy comparability guidelines may impact process
changes during development
• Global differences in data requirements for the transition from preclinical to clinical
trials
12:30 pm Lunch Break & Networking
1:30 pm Workshop B- Investment Workshop
Fuelling the Research Revolution: Strategies for Funding Success
Synopsis
A major bottleneck for much of the most innovative and impactful research is a lack
of adequate funding. In this investor workshop hear from decision makers in venture
capital, advanced therapy investment and business development leader in big
pharma. Hear what they are looking out for in future investments to consolidate your
financial strategy going forward
This workshop will cover:
• Key criteria investors use to assess funding potential of early-stage allogeneic
therapies
• Innovative technologies and clinical data that can catalyse wider investment into the
field
• Deal structures and licensing models commonly used for partnering on allogeneic
products
4:40 pm End of Pre-Conference Workshop Day
